Who owns Innate Pharma Adr?
- Ticker: IPHA
- CUSIP Number: 45781k204
Tip: Access positions for across all investors
Analyze quarterly positions in Innate Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Innate Pharma stock
Who bought or sold Innate Pharma Adr this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Exchange Traded Concepts | 113k | $326k | 141% | Mar 2024 |
|
| Optiver Holding B.V. | 71k | $203k | -63% | Mar 2024 |
|
| Morgan Stanley | 44k | $127k | -2% | Mar 2024 |
|
| Jane Street | 15k | $42k | 100% | Mar 2024 |
|
| Millennium Management | 11k | $31k | -12% | Mar 2024 |
|
| Barclays | 412.00 | $1.0k | 0% | Mar 2024 |
|
| UBS Group | 210.00 | $604.107000 | 44% | Mar 2024 |
|
| Rhumbline Advisers | 205.00 | $589.990000 | 0% | Mar 2024 |
|
| Steward Partners Investment Advisory | 200.00 | $576.000000 | 0% | Mar 2024 |
|